Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Mimedx Group (MDXG) EBT: 2011-2025

Historic EBT for Mimedx Group (MDXG) over the last 15 years, with Sep 2025 value amounting to $22.8 million.

  • Mimedx Group's EBT rose 100.10% to $22.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $55.7 million, marking a year-over-year decrease of 7.07%. This contributed to the annual value of $57.3 million for FY2024, which is 87.03% up from last year.
  • Mimedx Group's EBT amounted to $22.8 million in Q3 2025, which was up 75.67% from $13.0 million recorded in Q2 2025.
  • Over the past 5 years, Mimedx Group's EBT peaked at $23.2 million during Q2 2024, and registered a low of -$10.8 million during Q2 2022.
  • For the 3-year period, Mimedx Group's EBT averaged around $12.0 million, with its median value being $11.4 million (2024).
  • Within the past 5 years, the most significant YoY rise in Mimedx Group's EBT was 10,732.97% (2022), while the steepest drop was 505.72% (2022).
  • Quarterly analysis of 5 years shows Mimedx Group's EBT stood at $91,000 in 2021, then skyrocketed by 10,732.97% to $9.9 million in 2022, then soared by 41.13% to $13.9 million in 2023, then dropped by 19.15% to $11.2 million in 2024, then spiked by 100.10% to $22.8 million in 2025.
  • Its EBT was $22.8 million in Q3 2025, compared to $13.0 million in Q2 2025 and $8.6 million in Q1 2025.